Aurelia Bioscience

Our Pedigree

 Scientists at Aurelia Bioscience Ltd have over 70 years experience in drug discovery gained at several blue chip pharmaceutical companies including Hoffmann La Roche, Smith Kline Beecham, Glaxo-Wellcome, AstraZeneca and ICI.

 We have worked in pre-clinical discovery, designing and developing low, medium and high throughput assays for hits-to-lead, lead identification and lead optimisation drug discovery phases in both cellular and non-cellular assay formats. We have experience of a wide range of technologies designed to prosecute these activities in a scalable manner whilst bringing to bear technological developments that have the ability to probe ever further into the molecular interactions from which the drugs of the future may be identified.

 Our research area focus has been respiratory disease, inflammatory disease, oncology, CNS-pain and diabetes working on numerous disease targets in these areas